FLUDARABINE, CYCLOPHOSPHAMIDE, AND TOTAL-BODY IRRADIATION FOLLOWED BY CYCLOSPORINE AND MYCOPHENOLATE MOFETIL IN TREATING PATIENTS WHO ARE UNDERGOING A DONOR UMBILICAL CORD BLOOD TRANSPLANT FOR HEMATOLOGIC CANCER: